4 Byetta users’ deaths reported
- Share via
From Times Wire Services
Eli Lilly and Amylin Pharmaceuticals Inc. reported four new deaths in patients taking Byetta, even as the companies tried to shore up the safety profile of their diabetes drug.
The announcement comes a week after the Food and Drug Administration said two Byetta patients died of acute pancreatitis, sinking shares of both drug makers.
Eli Lilly Medical Director James Malone said the four had complicating medical conditions, which were probably the primary cause of death.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.